Monil Shah, PharmD, MBA

Clinical Development Strategy

Monil has over twenty years of pharmaceutical and biotechnology industry experience. He is Chief Development Officer at WindMIL Therapeutics and Chief Operating Officer of Brooklyn ImmunoTherapeutics. Previously, he was Medical Affairs Lead for Immuno-Oncology at Bristol-Myers Squibb ad Head of Clinical Operations and Development at Ventrus Biosciences. He was also involved in Oncology Development/Operations at Celgene, FibroGen, Novacea, Novartis and Amgen.